Proliferative Diabetic Retinopathy (PDR) Completed Phase 2 Trials for Bevacizumab (DB00112)

Back to Proliferative Diabetic Retinopathy (PDR)

Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic

IndicationStatusPhase
DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00776763
Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal BevacizumabTreatment
NCT01571232
Ozurdex for Treatment of Recalcitrant Diabetic Macular EdemaTreatment